• Je něco špatně v tomto záznamu ?

Venous thromboembolism - prevalence and risk factors in chronic venous disease patients

D. Musil, M. Kaletová, J. Herman,

. 2017 ; 32 (2) : 135-140. [pub] 20160709

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc18034139

Aims This study was aimed to investigate the prevalence of venous thromboembolism in patients with chronic venous disease and the impact of some intrinsic and extrinsic risk factors. Methods A retrospective study on 641 outpatients (489 women) with primary chronic venous disease (C0-C6). The prevalence of venous thromboembolism was evaluated according to sex, age, BMI, the presence of ≥1 first-degree siblings diagnosed with venous thromboembolism, CEAP clinical class, smoking and the use of hormone therapy. Results Venous thromboembolism episodes occurred in 32 patients (5%) with no gender predominance (OR 1.49, 95% CI = 0.90-2.45; p = 0.146). There was no increased RR of venous thromboembolism in the age group 46-69 years compared with patients aged ≤45 years ( p = 0.350). In persons aged ≥70 years, the risk of venous thromboembolism was 3.2 times higher than in patients aged 46-69 years and 4.78 times higher than in patients aged ≤45 years. The risk of venous thromboembolism rose very significantly in obese compared with normostenic patients ( p = 0.002). There were significantly more venous thromboembolism episodes in patients with chronic venous insufficiency (55.3%) than patients with varicose veins (44.7%) ( p < 0.001). A family history of venous thromboembolism ( p = 0.12), smoking ( p = 0.905) and hormone therapy ( p = 0.326) were not associated with increased risk of venous thromboembolism. Smoking was a risk factor in obese patients ( p = 0.033), but the combination of obesity, smoking, estrogens in women did not increase the risk of venous thromboembolism. Conclusions The 5% prevalence of venous thromboembolism episodes in patients was comparable with the prevalence of venous thromboembolism in the general European population. Age ≥70 years and obesity were strongly associated with an occurrence of venous thromboembolism. Obese patients with chronic venous disease were at higher risk for venous thromboembolism than obese people in the general population. A family history of venous thromboembolism, smoking and estrogens alone or in combination were not revealed as significant risk factors.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18034139
003      
CZ-PrNML
005      
20181012102440.0
007      
ta
008      
181008s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1177/0268355516633392 $2 doi
035    __
$a (PubMed)26911618
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Musil, Dalibor $u 1 Department of Internal Medicine I - Cardiology, Teaching Hospital, Olomouc, Czech Republic.
245    10
$a Venous thromboembolism - prevalence and risk factors in chronic venous disease patients / $c D. Musil, M. Kaletová, J. Herman,
520    9_
$a Aims This study was aimed to investigate the prevalence of venous thromboembolism in patients with chronic venous disease and the impact of some intrinsic and extrinsic risk factors. Methods A retrospective study on 641 outpatients (489 women) with primary chronic venous disease (C0-C6). The prevalence of venous thromboembolism was evaluated according to sex, age, BMI, the presence of ≥1 first-degree siblings diagnosed with venous thromboembolism, CEAP clinical class, smoking and the use of hormone therapy. Results Venous thromboembolism episodes occurred in 32 patients (5%) with no gender predominance (OR 1.49, 95% CI = 0.90-2.45; p = 0.146). There was no increased RR of venous thromboembolism in the age group 46-69 years compared with patients aged ≤45 years ( p = 0.350). In persons aged ≥70 years, the risk of venous thromboembolism was 3.2 times higher than in patients aged 46-69 years and 4.78 times higher than in patients aged ≤45 years. The risk of venous thromboembolism rose very significantly in obese compared with normostenic patients ( p = 0.002). There were significantly more venous thromboembolism episodes in patients with chronic venous insufficiency (55.3%) than patients with varicose veins (44.7%) ( p < 0.001). A family history of venous thromboembolism ( p = 0.12), smoking ( p = 0.905) and hormone therapy ( p = 0.326) were not associated with increased risk of venous thromboembolism. Smoking was a risk factor in obese patients ( p = 0.033), but the combination of obesity, smoking, estrogens in women did not increase the risk of venous thromboembolism. Conclusions The 5% prevalence of venous thromboembolism episodes in patients was comparable with the prevalence of venous thromboembolism in the general European population. Age ≥70 years and obesity were strongly associated with an occurrence of venous thromboembolism. Obese patients with chronic venous disease were at higher risk for venous thromboembolism than obese people in the general population. A family history of venous thromboembolism, smoking and estrogens alone or in combination were not revealed as significant risk factors.
650    _2
$a dospělí $7 D000328
650    _2
$a chronická nemoc $7 D002908
650    _2
$a estrogeny $x aplikace a dávkování $x škodlivé účinky $7 D004967
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hormonální substituční terapie $7 D020249
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a obezita $x epidemiologie $x patofyziologie $7 D009765
650    _2
$a prevalence $7 D015995
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a rizikové faktory $7 D012307
650    _2
$a kouření $x škodlivé účinky $x epidemiologie $7 D012907
650    _2
$a žilní tromboembolie $x epidemiologie $x patofyziologie $7 D054556
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Kaletová, Markéta $u 1 Department of Internal Medicine I - Cardiology, Teaching Hospital, Olomouc, Czech Republic.
700    1_
$a Herman, Jiří $u 2 Department of Surgery II - Vascular and Transplantation Surgery, Teaching Hospital, Olomouc, Czech Republic.
773    0_
$w MED00003815 $t Phlebology $x 1758-1125 $g Roč. 32, č. 2 (2017), s. 135-140
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26911618 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20181012102932 $b ABA008
999    __
$a ok $b bmc $g 1340459 $s 1031133
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 32 $c 2 $d 135-140 $e 20160709 $i 1758-1125 $m Phlebology $n Phlebology $x MED00003815
LZP    __
$a Pubmed-20181008

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...